Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer-related molecular mechanisms research, Circular RNAs in diseases, MicroRNA in disease regulation, and RNA modifications and cancer.
Correction: Circular RNA F-circSR derived from SLC34A2-ROS1 fusion gene promotes cell migration in non-small cell lung cancer.
SLIRP maintains energy metabolism homeostasis in colorectal cancer by stabilizing mitochondrial-encoded mRNAs.
Intranasal circRNA vaccine elicits localized and safer antitumor immunity
Trispecific antibodies: is more always better? Advances and boundaries
circPLEKHM1 promotes tumor growth and metastasis through enhancing FXR1-mediated protein translation in PDAC
Single-cell transcriptomic analysis reveals gut microbiota-immunotherapy synergy through modulating tumor microenvironment.
Low-input redoxomics facilitates global identification of metabolic regulators of oxidative stress in the gut.
A circular RNA overcomes acquired resistance to BET inhibitors by antagonizing IGF2BP2-mediated c-MYC translation in TNBC.
Small open reading frame-encoded microproteins in cancer: identification, biological functions and clinical significance.
Acetylation profiling by Iseq-Kac reveals insights into HSC aging and lineage decision.
The Long Noncoding RNA LINC02820 Promotes Tumor Growth and Metastasis Through Regulating MYH9 Expression in Esophageal Squamous Cell Carcinoma.
Role of noncoding RNA and protein interaction in pancreatic cancer.
Optimization of 1-Methyl-3-(pyridin-3-yl)-1<i>H</i>-indol Derivatives as ROR1 Inhibitors with Improved Activity and Selectivity.
Spatial transcriptomic analysis of tumor microenvironment in esophageal squamous cell carcinoma with HIV infection.
Rational Design, Synthesis, and Biological Evaluation of Novel c-Met Degraders for Lung Cancer Therapy.
A positive feedback loop between TNS1 and ZEB1 promotes TGFβ-induced epithelial-to-mesenchymal transition in lung cancer.
Decoding the intracellular trafficking rule for circular RNAs.
NKp46 enhances type 1 innate lymphoid cell proliferation and function and anti-acute myeloid leukemia activity.
Antibody-based targeted protein degradation for membrane and extracellular proteins: emerging strategies and breakthroughs.
Identification of Small Open Reading Frame-Encoded Peptides in Glioma by an Optimized Proteomics Strategy.
Discovery of a Novel G9a-Selective Inhibitor for Hepatocellular Carcinoma Treatment.
A Circular RNA Promotes Tumor Metastasis through Stabilizing MSI2 Protein in Pancreatic Ductal Adenocarcinoma.
Structure-directing optimization of N-(2,3-dihydrobenzo[b] [1,4]dioxin-6-yl)benzamide derivatives as selective receptor tyrosine kinase-like orphan receptor 1 (ROR1) inhibitors for cancer therapy.
Publisher Correction: Acetylation profiling by Iseq-Kac reveals insights into HSC aging and lineage decision.
Structure-Guided Optimization and Preclinical Evaluation of 6-<i>O</i>-Benzylguanine-Based Pin1 Inhibitor for Hepatocellular Carcinoma Treatment.
Interaction and Reciprocal Stabilization of H3.3 and PARP1 Promote DNA Damage Repair and Tumor Progression in Small Cell Lung Cancer.
Figure S8 from Interaction and Reciprocal Stabilization of H3.3 and PARP1 Promote DNA Damage Repair and Tumor Progression in Small Cell Lung Cancer
Figure S6 from Interaction and Reciprocal Stabilization of H3.3 and PARP1 Promote DNA Damage Repair and Tumor Progression in Small Cell Lung Cancer
Figure S1 from Interaction and Reciprocal Stabilization of H3.3 and PARP1 Promote DNA Damage Repair and Tumor Progression in Small Cell Lung Cancer
Table S2 from Interaction and Reciprocal Stabilization of H3.3 and PARP1 Promote DNA Damage Repair and Tumor Progression in Small Cell Lung Cancer